PATENT CLAIM ANALYSIS

Application Number: 16256987
Application Type: Utility
Filing Date: 2019-01
Publication Date: 2019-08
Patent Classification: ["514", "260100"]

Abstract:
Disclosed herein, inter alia, are compounds and methods of use thereof for the modulation of certain chemokine receptor activity.

Claim (Index 3):
The compound of  claim 1 , or a pharmaceutically acceptable salt thereof, wherein z4 is 1.

Metadata:
- Claim Count in Document: 152.0
- Percentile: 99.0
- Lexical Diversity: 1.1
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15662861', '15700040', '16195506', '15757238', '16016290']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8568121280618284
- 35 USC 102 Novelty (BERT): 0.6244287238033693
- Combined Prediction Score: 0.8335737876359826
- Mean Citation Score: 563.0521120000002
- Max Citation Score: 632.4801
- Similarity Product: 516.2664974601566

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test